三季报显示，2025年前三季度，新宙邦营业收入为66.16亿元，同比增长16.75%；归母净利润为7.48亿 元，同比增长6.64%；扣非归母净利润为7.15亿元，同比增长1.26%。 电池化学品业务主要产品有锂离子电池化学品(包括锂离子电池电解液、添加剂、新型锂盐、碳酸酯溶 剂)、超级电容器化学品、一次锂电池化学品、钠离子电池化学品、固态电池化学材料等。下游市场包 括动力电池、储能电池和消费类电池，应用领域非常广泛，主要在电动汽车、电力系统、数据中心、轨 道交通、风电和光伏、笔记本电脑、平板、智能手机、智能穿戴设备、消费类无人机、机器人、智能电 器、电动工具以及各种便携式移动电子产品等终端领域。 智通财经APP获悉，12月11日，新宙邦(300037.SZ)发布公告称，为深入推进公司全球化发展战略，实现 全球资源本地化供应，提升国际品牌形象以及在全球市场的综合竞争实力，公司拟发行境外上市外资股 (H股)股票并申请在香港联合交易所有限公司主板挂牌上市，本次发行上市尚需提交公司股东会审议， 并需取得中国证券监督管理委员会、香港证券及期货事务监察委员会和香港联交所等相关政府机构、监 管机构备案、批准和/或核准。 ...

Group 1 - Lu Kang Pharmaceutical plans to increase capital by 109 million yuan to its wholly-owned subsidiary Bio-Pesticide Company and 27 million yuan to Ze Run Company, aiming to expand its pesticide and sales sectors [1] - Hui Green Ecology intends to sell two properties in Ningbo for 12.52 million yuan, expecting a net profit impact of approximately 6.23 million yuan from the transaction [2] - Tianyuan Co., Ltd. plans to invest 185 million yuan in an intelligent upgrade project for its titanium dioxide production facilities [3] Group 2 - Metro Design has received approval from the Shenzhen Stock Exchange for its share issuance to acquire 100% equity of Guangzhou Metro Engineering Consulting Co., Ltd. for 511 million yuan [4] - South Network Energy announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 0.07 yuan per 10 shares [5] - Qibin Group plans to establish two wholly-owned subsidiaries in Shenzhen with a registered capital of 100 million yuan each [6] Group 3 - All New Good received an administrative regulatory decision from the Shenzhen Securities Regulatory Bureau due to issues in financial accounting and information disclosure [7] - Luokai Co., Ltd. announced that its shareholders plan to reduce their holdings by up to 3% of the company's shares [8][9] - Jincheng Pharmaceutical's actual controller received an administrative penalty from the CSRC for stock manipulation, leading to the resignation of the chairman [10] Group 4 - Yicheng New Energy intends to acquire a 7.69% stake in Kaifeng Times for 10 million yuan, enhancing its strategic development [11] - Yujing Co., Ltd. signed a sales contract worth approximately 28.6 million USD with an overseas photovoltaic company [12] - Nuocheng Jianhua's TRK inhibitor, Zoltracitinib, has been approved for market entry in China [13] Group 5 - Nandu Power announced that its controlling shareholder is planning a change in control, leading to a temporary suspension of its stock [14] - Xinxing Casting plans to acquire 100% equity of China Resources Steel for 1.244 billion yuan to focus on special steel development [15] - Xinlitai is planning to issue H-shares and list on the Hong Kong Stock Exchange [16] Group 6 - Blue Fan Medical's subsidiary received approval for a new medical device, the coronary artery scoring balloon dilation catheter [18] - China Iron & Steel plans to establish a joint venture with several companies to provide new energy transportation solutions with a registered capital of 500 million yuan [19] - Jifeng Technology intends to sign a cooperation framework agreement with Dongtai Lianfei for a total transaction amount not exceeding 100 million yuan [20] Group 7 - Zhongwei Electronics announced a change in its actual controller, with stock resuming trading [21] - Weihong Co., Ltd. plans to reduce its holdings by up to 1.15% of the company's shares [22] - Te Fa Information received a criminal judgment related to a fraud case involving the acquisition of Shenzhen Te Fa Dongzhi Technology Co., Ltd. [23] Group 8 - Sunshine Dairy's controlling shareholder's concerted action plans to reduce holdings by up to 3% of the company's shares [24] - Meikailong reported that Taobao Holdings and New Retail Fund collectively reduced their H-shares by 30.616 million shares [25] - Xinjubang plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [26] Group 9 - Beite Technology's application for issuing A-shares to specific objects has been approved by the Shanghai Stock Exchange [28] - Victory Energy's controlling shareholder is planning a change in control, with stock resuming trading [29] - Jiutian Pharmaceutical signed a patent and technology transfer agreement for a small molecule analgesic drug project, with a total transfer fee not exceeding 400 million yuan [29]

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-101 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | ●限制性股票授予日：2025 年 12 月 11 日 ●限制性股票授予数量：163.60 万股 ●限制性股票预留授予价格：19.43 元/股（调整后） ●股权激励工具：第二类限制性股票 2、2025年4月9日，公司召开第六届监事会第十九次会议审议通过了《关于 公司<2025年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2025 年限制性股票激励计划实施考核管理办法>的议案》《关于核实公司<2025年限 制性股票激励计划首次授予部分激励对象名单>的议案》。 深圳新宙邦科技股份有限公司 关于向2025年限制性股票激励计划激励对象 预留授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 《深圳新宙邦科技股份有限公司 2025 年限制性股票激励计划（草案）》（以 下简称"《2025 年激励计划（草案）》"或"本激励计划"或"2025 年激励计 ...

3、上表中部分合计数与各明细数直接相加之和在尾数上如有差异，是由于四舍五入所造成。 深圳新宙邦科技股份有限公司 2025 年限制性股票激励计划预留授予部分激励对象名单 （授予日） | 序号 | 姓名 | 国籍 | 职务 | 获授的限制 性股票数量 | 占授予限制 | 占公司 股本总 | | --- | --- | --- | --- | --- | --- | --- | | | | | | （万股） | 性股票总数 的比例 | 额的比 | | | | | | | | 例 | | 1 | 谢伟东 | 中国 | 董事、副总裁 | 1 | 0.611% | 0.001% | | 2 | 周艾平 | 中国 | 董事、常务副 总裁 | 1 | 0.611% | 0.001% | | 3 | 姜希松 | 中国 | 副总裁 | 1 | 0.611% | 0.001% | | 4 | 宋慧 | 中国 | 副总裁 | 1 | 0.611% | 0.001% | | 5 | 黄瑶 | 中国 | 财务总监 | 1 | 0.611% | 0.001% | | 6 | 贺靖策 | 中国 | 董事会秘书 | 1 | 0.611% | ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2025-100 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 4、2025年4月28日，公司2025年第一次临时股东大会审议通过了《关于公司 <2025年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2025年限 制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会授权董事会 办理2025年限制性股票激励计划相关事宜的议案》。 关于调整公司2025年限制性股票激励计划相关事项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要提示： 深圳新宙邦科技股份有限公司（以下简称"公司"）于 2025 年 12 月 11 日 召开第六届董事会第二十六次会议，审议通过了《关于调整公司 2025 年限制性 股票激励计划相关事项的议案》，根据公司《2025 年限制性股票激励计划（草 案）》（以下简称"《2025 年激励计划（草案）》"）及公司 2025 年第一次临 时股东大会的授权，公司董事会对 20 ...

Group 1: Economic Policy and Industry Development - The Central Economic Work Conference emphasized the need for stable economic growth and quality improvement, advocating for a more proactive fiscal policy and maintaining necessary fiscal deficits and debt levels [2] - The Ministry of Commerce plans to support the retail industry's innovation and high-quality development during the 14th Five-Year Plan, focusing on enhancing product and service quality and promoting fair competition between online and offline channels [3] - The China Automobile Industry Association reported that in November, automobile production exceeded 3.5 million units for the first time, with year-to-date production and sales surpassing 31 million units, both showing over 10% growth year-on-year [4] Group 2: Company News - Moore Threads is currently in the research phase for new products and architectures, with mass production and revenue generation expected to take some time [6] - ZTE Corporation is aware of media reports regarding compliance investigations related to the U.S. Foreign Corrupt Practices Act and is in communication with the U.S. Department of Justice [6] - Nandu Power's controlling shareholder is planning a change in control, leading to a suspension of its stock [6] - Victory Energy's controlling shareholder will change to Qiteng Robotics, and the stock will resume trading [7] - China Iron & Steel Logistics plans to establish a joint venture with China Storage Group to provide new energy logistics solutions [7] - Xinlitai is planning to issue H-shares and list on the Hong Kong Stock Exchange [7] - Zhaoxin Co. intends to acquire a 70% stake in the new energy operation and maintenance company Youde New Energy [7] - New Zhou Bang plans to issue H-shares and list on the Hong Kong Stock Exchange [7]

（文章来源：证券日报） 证券日报网讯 12月11日晚间，新宙邦发布公告称，选举周艾平先生为公司第七届董事会职工代表董 事。 ...

（文章来源：证券日报） 证券日报网讯 12月11日晚间，新宙邦发布公告称，《深圳新宙邦科技股份有限公司 2025 年限制性股票 激励计划（草案）》（以下简称"《2025 年激励计划（草案）》"或"本激励计划"或"2025 年激励计 划"）规定的限制性股票授予条件已经成就，根据深圳新宙邦科技股份有限公司（以下简称"公司"） 2025 年第一次临时股东大会授权，公司于 2025 年 12 月 11日召开的第六届董事会第二十六次会议，审 议通过了《关于向 2025 年限制性股票激励计划激励对象预留授予限制性股票的议案》，确定以 2025 年 12 月 11日为预留授予日，向符合授予条件的 259 名激励对象授予 163.60 万股限制性股票。 ...

责任编辑：山上 格隆汇12月11日丨新宙邦(300037.SZ)公布，为深入推进公司全球化发展战略，实现全球资源本地化供 应，提升国际品牌形象以及在全球市场的综合竞争实力，打造国际化资本运作平台，优化资本结构和股 东组成，提升公司治理水平和核心竞争力，根据相关法律、法规、规范性文件的要求，公司拟发行境外 上市外资股（H股）股票并申请在香港联合交易所有限公司（简称"香港联交所"）主板挂牌上市。 股票频道更多独家策划、专家专栏，免费查阅>> ...

每经AI快讯，新宙邦（SZ 300037，收盘价：48.57元）12月11日晚间发布公告称，公司第六届第二十六 次董事会会议于2025年12月11日在公司会议室以现场结合通讯方式召开。会议审议了《关于2026年度日 常关联交易预计的议案》等文件。 （记者 曾健辉） 2025年1至6月份，新宙邦的营业收入构成为：化工行业占比100.0%。 截至发稿，新宙邦市值为363亿元。 每经头条（nbdtoutiao）——专访管涛：美国政府经济贸易政策正逐渐动摇美元本位国际货币体系，利 多因素下人民币汇率有可能破7 ...